{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-058239","form_type":"8-K","ticker":"RYAN","cik":"0001849253","company_name":"RYAN SPECIALTY HOLDINGS, INC.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.030058+00:00","generated_at":"2026-06-09T00:57:35.394904+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ryan Specialty Q3 revenue up 21.8% to $502M; adj. diluted EPS $0.32 beats prior year","bullets":["Total revenue $501.9M, up 21.8% YoY; organic growth rate 14.7%.","Net income $15.7M vs $29.3M YoY; GAAP diluted loss per share $(0.04) due to discrete deferred tax expense.","Adjusted EBITDAC $147.0M, up 25.8%; margin expanded to 29.3% from 28.4%.","Adjusted net income $86.6M, up 30.2%; adjusted diluted EPS $0.32, up 28.0%.","Agreed to acquire AccuRisk to expand benefits practice; three acquisitions closed in July 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-058239","json":"https://secwatch.observer/filing/0000950170-23-058239.json","markdown":"https://secwatch.observer/filing/0000950170-23-058239.md","text":"https://secwatch.observer/filing/0000950170-23-058239.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1849253/000095017023058239/0000950170-23-058239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1849253/000095017023058239/ryan-20220930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:57:35.394904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"96290d667bc6ad7347a5d9926f46a35ec3f9ecfa","claim":"RYAN SPECIALTY HOLDINGS, INC. reported third quarter ended September 30, 2023 results: revenue $501.9 million, net income $15.7 million, EPS $(0.04) per diluted share.","evidence_excerpt":"forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 RYAN SPECIALTY REPORTS THIRD QUARTER 2023 RESULTS - Total Revenue grew 21.8% year-over-year to $501.9 million - - Organic Revenue Growth Rate of 14.7% year-over-year - - Net Income of $15.7 million, or $(0.04) per diluted share 1 - - Adjusted EBITDAC grew 25.8% year-over-year to $147.0","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1849253/000095017023058239/0000950170-23-058239-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$501.9 million"},{"label":"Net income","value":"$15.7 million"},{"label":"EPS","value":"$(0.04) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}